Baldwin Wealth Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
VCM
VPM
Baldwin Wealth Partners's IDXX Position: Q1 2026 in Review
Baldwin Wealth Partners sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 347 shares — an estimated $235K sold.
Baldwin Wealth Partners first reported a position in IDXX in Q4 2016 and held it in 25 quarters. The position peaked at $6M in Q3 2020. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Baldwin Wealth Partners reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- Baldwin Wealth Partners sold 347 Idexx Laboratories shares in Q1 2026, an estimated $235K.
- Baldwin Wealth Partners first reported a position in Idexx Laboratories in Q4 2016 and held it in 25 quarters.
- Baldwin Wealth Partners's Idexx Laboratories position peaked at $6M in Q3 2020.
- 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Baldwin Wealth Partners's 13F filing for Q1 2026, filed 14 Apr 2026.